Reyes María Martín-Rojas (Reyes Martín, Reyes Maria Martín-Rojas)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Liquid Chromatography

Positron Emission Tomography

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Clinical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Reyes María Martín-Rojas, Lucía Cayuela, Francisco Martín-Domínguez, Aurelio Cayuela Domínguez
Unveiling sex-based geographical disparities in myelodysplastic syndrome mortality trends in Spain (1999-2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Reyes María Martín-Rojas, Lucía Cayuela, Francisco Martín-Domínguez, Aurelio Cayuela Domínguez
Myelodysplastic syndromes mortality in Spain: a comprehensive age-period-cohort and joinpoint analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Reyes María Martín-Rojas, Ignacio Gómez-Centurión, Rebeca Bailén, Mariana Bastos-Oreiro, Francisco Diaz-Crespo, Diego Carbonell, Rafael Correa-Rocha, Marjorie Pion, Cristina Muñoz, Milagros Sancho, Isabel Gómez Fernández, Gillen Oarbeascoa, Ana Pérez-Corral, Carolina Martínez-Laperche, Javier Anguita, Ismael Buño, Javier Menárguez, Jose Luis Díez-Martín, Mi Kwon
Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel. Clinical case reports 10 (1) (2022)
Mariana Bastos Oreiro, Reyes María Martín-Rojas, Pilar Gomez, Nieves López Muñoz, Antonia Rodriguez, Marta Liébana, Belén Navarro, Blanca Sánchez-González, Pilar Marí, Jaime Pérez de Oteyza, Antonio Gutierrez, Leyre Bento, Eva Domingo Doménech, María Jesús Vidal, Raquel Del Campo, Alicia Roldán Pérez, Daniel García Belmonte, Alicia Roldán, Daniel García Belmonte, Miriam Santero, Anna Sureda, Ramón García Sanz, null On Behalf Of The Geltamo Group
SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment. Cancers 13 (10) (2021)